Association between CD4 T lymphocyte levels and oral lesions in HIV/AIDS patients
Keywords:
HIV/AIDS, CD4 T lymphocytes, oral candidiasis, Kaposi sarcoma, herpes simplex virus 1.Abstract
Introduction: Oral diseases may be aggravated in HIV/AIDS patients depending on their immune response and lymphocyte levels. Objective: Describe the relationship between CD4 T lymphocyte levels and the main oral lesions in HIV/AIDS patients from Hipólito Unanue National Hospital in Lima, Peru, during the year 2018. Methods: An analytical cross-sectional study was conducted of 65 hospitalized patients from July to October 2018. The patients underwent oral clinical examination. Evaluation was performed of the presence of HIV/AIDS-related oral manifestations, and CD4 T lymphocyte levels were classified into three categories: > 500 cell/mm3, 200-500 cell/mm3 and < 200 cell/lmm3. Results: Of the total patients studied, 70.8% were not under antiretroviral treatment at the moment of the examination. Average CD4 T lymphocyte level was 237.65 cell/mm3, with higher results among women. 56.9% of the patients had oral lesions. Males were more commonly affected (91%). The most frequent lesion type was oral candidiasis (44.6%), whereas the category presenting the highest frequency of oral lesions was < 200 cell/mm3 (38.5%; p < 0.05). Conclusions: Male patients presented the largest number of oral lesions associated to low CD4 T lymphocyte levels. Most of the oral lesions were found at a CD4 T lymphocyte level < 200 cell/mm3. Oral candidiasis was the lesion most commonly found by the clinical examination.
Downloads
References
Lahoti S, Rao K, Umadevi HS, Mishra L. Correlation of mucocutaneous manifestations of HIV-infected patients in an ART center with CD4 counts. Indian J Dent Res. 2017;28(5):549-54. PMID: 29072219
Ratnam M, Nayyar AS, Reddy DS, Ruparani B, Chalapathi KV, Azmi SM. CD4 cell counts and bucal manifestations in HIV infected and AIDS patients. J Bucal Maxillofac Pathol. 2018;22(2):282. PMID: 30158790
Frimpong P, Amponsah EK, Abebrese J, Kim SM. Bucal manifestations and their correlation to baseline CD4 count of HIV/AIDS patients in Ghana. J Korean Assoc Bucal Maxillofac Surg. 2017;43(1):29-36. PMID: 28280707
Berberi A, Noujeim Z. Epidemiology and Relationships between CD4+ Counts and Bucal Lesions among 50 Patients Infected with Human Immunodeficiency Virus. J Int Bucal Health. 2015;7(1):18-21. PMID: 25709361
Lu CL, Pai JA, Nogueira L, Mendoza P, Gruell H, Oliveira TY, et al. Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption. Proc Natl Acad Sci (EE. UU.). 2018;115(48):E11341-8. PMID: 30420517
Berberi A, Aoun G. Bucal lesions associated with human immunodeficiency virus in 75 adult patients: a clinical study. J Korean Assoc Bucal Maxillofac Surg. 2017;43(6):388-94. PMID: 29333368
Chandrakala C, Parimalam K, Wahab AJ, Anand N. Correlating CD4 count with mucocutaneous manifestations in HIV-positive patients: A prospective study. Indian J Sex Transm Dis AIDS. 2017;38(2):128-135. PMID: 30148265
Satyakiran GV, Bavle RM, Alexander G, Rao S, Venugopal R, Hosthor SS. A relationship between CD4 count and bucal manifestations of human immunodeficiency virus-infected patients on highly active antiretroviral therapy in urban population. J Bucal Maxillofac Pathol. 2016;20(3):419-26. PMID: 27721607
Tappuni AR, Flemming GJ. The effect of antiretroviral therapy on the prevalence of bucal manifestations in HIV-infected patients: a UK study. Bucal Surg Bucal Med Bucal Pathology Bucal Radio Endodontics. 2001[acceso: 06/11/2019]; 92(6):623-8. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1079-2104(01)75952-5
Taylor BS, Tieu HV, Jones J, Wilkin TJ. CROI 2019: advances in antiretroviral therapy. Top Antivir Med. 2019;27(1):50-68. PMID: 31137003
Gallardo R, Castillo K, Alegría P, Blackburn E. Manifestaciones Bucales en pacientes VIH/sida del Hospital Base de Valdivia en Chile. Rev CES Odont. 2016 [acceso: 16/12/2019]; 29(2):12-9. Disponible en: http://www.scielo.org.co/scielo.php?pid=S0120-971X2016000200003&script=sci_abstract&tlng=en
World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013;27;310(20):2191-4. PMID: 24141714
Shiboski CH, Patton L, Webster-Cyriaque JY, Greenspan D, Traboulsi R, Ghannoum M. The Bucal HIV/AIDS Research Alliance: updated case definitions of bucal disease endpoints. J Bucal Pathol Med. 2009 [acceso: 16/12/2019]; 38:481-8. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1600-0714.2009.00749.x
Classification and diagnostic criteria for bucal lesions in HIV infection. EC-Clearinghouse on Bucal Problems Related to HIV Infection and WHO Collaborating Centre on Bucal Manifestations of the Immunodeficiency Virus. J Bucal Pathol Med. 1993;22:289-91. PMID: 8229864
Saavedra A. Manifestaciones clínicas bucales en pacientes VIH/sida en el servicio de infectología Hospital Nacional Hipólito Unanue en el año 2014 [Tesis de bachiller]. Lima: Universidad Nacional Mayor de San Marcos; 2016. [acceso: 16/12/2019]. Disponible en: http://cybertesis.unmsm.edu.pe/handle/cybertesis/4908
Taivo D. Manifestaciones bucomaxilofaciales en pacientes adultos VIH/sida del Hospital San Juan de Dios y su relación con recuento de linfocitos TCD4+ y carga viral [Tesis de bachiller]. Santiago de Chile: Universidad de Chile, Departamento de Cirugía y Traumatología Maxilofacial; 2015. [acceso: 16/12/2019]. Disponible en: http://repositorio.uchile.cl/handle/2250/141563
Donoso-Hofer F. Oral lesions associated with human immunodeficiency virus disease in adult patients, a clinical perspective. Rev Chilena Infectol. 2016;33(Suppl 1):27-35. PMID: 28453025
Harris J, Herrera A. Candidiasis bucal en pacientes VIH/sida asociada a niveles de linfocitos T CD4 y terapia antirretroviral. Rev Cubana Estomatol. 2016 [acceso: 16/12/2019]; 53(1):9-14. Disponible en: http://www.revestomatologia.sld.cu/index.php/est/article/view/785/246
Vohra P, Jamatia K, Subhada B, Vinay R, Tiwari C, Nabeel MS, et al. Correlation of CD4 counts with oral and systemic manifestations in HIV patients. J Family Med Prim Care. 2019;8(10):3247-52. PMCID: PMC6857402
Frimpong P, Kofi EA, Abebrese J, Min SK. Oral manifestations and their correlation to baseline CD4 count of HIV/AIDS patients in Ghana. J Korean Assoc Oral Maxillofac Surg. 2017;43(1):29-36. PMCID: PMC5342969
Ramírez V, Esquivel L, Sierra J, Anaya G, González I. The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV) related Bucal Lesions in 1,000 Consecutive Patients: A 12-Year Study in a referral Center in Mexico. Medicine (Baltimore). 2003 [acceso: 12/01/2020]; 82(1):39-50. Disponible en: https://insights.ovid.com/crossref?an=00005792-200301000-00004
Donoso F. Lesiones bucales asociadas con la enfermedad del virus de inmunodeficiencia humana en pacientes adultos, una perspectiva clínica. Rev Chilena Infectol. 2016 [acceso: 12/01/2020]; 33(1):27-35. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0716-10182016000700004
Pakfetrat A, Falaki F, Delavarian Z, Dalirsani Z, Sanatkhani, Marani M. Bucal Manifestations of Human Immunodeficiency Virus-Infected Patients. Iran J Otorhinolaryngol. 2015;27(1):78. PMID: 25745611
Medina NE, Brett MM, Betancourt FA, Patiño JC. Frecuencia de lesiones en cavidad bucal de pacientes con VIH/sida en el Hospital Universitario San Ignacio de Bogotá, Colombia. Univ Odontol. 2012 [acceso: 12/01/2020]; 31(66):51-8. Disponible en: https://revistas.javeriana.edu.co/index.php/revUnivOdontologica/article/view/2713
Bravo M, Correnti M, Escalona L, Perrone M, Brito A, Tovar V, et al. Prevalence of bucal lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population. Med Bucal Patol Bucal Cir Bucal. 2006 [acceso: 12/01/2020]; 11:33-9. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1698-69462006000100008
Downloads
Published
How to Cite
Issue
Section
License
Authors retain all rights to their works, which they can reproduce and distribute as long as they cite the primary source of publication.
The Rev Cubana Estomatol is subject to the Creative Commons Attribution-Non-Commercial 4.0 International License (CC BY-NC 4.0) and follows the publication model of SciELO Publishing Schema (SciELO PS) for publication in XML format.
You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
- You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
- No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.